20.07.2011 • NewsBASFBahrainunder construction

BASF to Build CSB Plant in Bahrain

BASF has announced it will build a state-of-the-art plant for customer specific antioxidant blends (CSB) in Bahrain. CSBs are key additives for the production of polymers for the plastics industry, especially for the Middle East region. Construction of the new facility will start in September. It will become one of the world's largest CSB plants with an annual capacity of about 16,000 metric tons. The new plant will be operational already by end of 2012.

This new plant will come in addition to the existing manufacturing agreement for CSBs with Astra Polymer in the Kingdom of Saudi Arabia, making BASF the largest CSB supplier in this region, the company said. BASF also said that the facility will be well positioned to serve the fast growing polymer market in the Middle East with special focus on key customers in the countries of the Gulf Cooperation Council (GCC), one of the fastest growing regions for the production of polyolefin resins worldwide.

 

 

Interview

Specialty Chemicals in a Shifting World
Adapting to Tariffs and Strengthening Regional Networks

Specialty Chemicals in a Shifting World

Jennifer Abril, President & CEO of SOCMA, discusses the impact of new tariffs and the importance of regional supply networks in the specialty chemical industry.

Virtual Event

Digitalization in the Chemical Industry
CHEManager Spotlight

Digitalization in the Chemical Industry

Save the Date: October 22, 2025
The event will be promoted to a combined audience of over 100,000 professionals across Europe through the CHEManager and CITplus networks.

most read

Photo
21.03.2025 • News

What’s Next for Pharma Supply Chains?

Sudden shifts in demand, supply shortages and global collapse have put immense pressure on pharmaceutical logistics. To address these challenges, PHARMAP 2025 brings together industry experts to discover AI-driven supply chain optimisation, strategic logistics partnerships and digital solutions that enhance efficiency and resilience in the pharmaceutical supply chain.